3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Ovarian Neoplasms
12
Fallopian Tube Neoplasms
8
Sarcoma
2
Neoplasms
2
Neoplasm Metastasis
2
Multi-centric Castleman's Disease
2
Breast Neoplasms
2
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Uterine Cervical Neoplasms
1
Sarcoma, Synovial
1
Sarcoma, Kaposi
1
Sarcoma, Ewing
1
Recurrent Platinum-Sensitive Fallopian Tube Endometrioid Adenocarcinoma
1
Recurrent Epithelial Ovarian, Fallopian or Peritoneal Carcinoma
1
Peritoneal Neoplasms
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Ovarian Cancer Recurrent
1
Macular dystrophy, corneal type 1
1
Lymphoproliferative Disorders
1
Lymphadenopathy
1
Liposarcoma
1
Leiomyosarcoma
1
Hodgkin Disease
1
Histiocytoma, Malignant Fibrous
1
HIV Infections
1
Gliosarcoma
1
Glioblastoma
1
Fallopian Tube Mucinous Adenocarcinoma
1
Endometrial Neoplasms
1
Interventions
fludarabine
17
Cyclophosphamide
15
Specimen Handling
14
Biopsy
12
fludarabine phosphate
11
Melphalan
10
Cytarabine
10
Busulfan
10
Mycophenolic Acid
9
Whole-Body Irradiation
8
Tacrolimus
8
venetoclax
7
decitabine and cedazuridine drug combination
7
Granulocyte Colony-Stimulating Factor
7
Injections
6
Cyclosporine
6
Stem Cell Transplantation
5
Sirolimus
5
Filgrastim
5
Azacitidine
5
X-Rays
4
Thiotepa
4
Peripheral Blood Stem Cell Transplantation
4
Idarubicin
4
CPX-351
4
ruxolitinib
3
Magnetic Resonance Spectroscopy
3
Hematopoietic Stem Cell Transplantation
3
Decitabine
3
treosulfan
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Myelodysplastic Syndromes
×
liposomal doxorubicin
×
30 days
×
Clear all
No trials found.